Earnings History Data for Sarepta Therapeutics (SRPT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Sarepta Therapeutics

Sarepta Therapeutics, Inc. focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy. Sarepta Therapeutics, Inc., formerly known as AVI BioPharma, Inc., is headquartered in Bothell, Washington.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
28-02-2024 AH SRPT Sarepta Therapeutics 12,772 0.47 -0.03 0.00 Sarepta Therapeutics Non-GAAP EPS of $0.82 beats by $0.45, revenue of $396.78M beats by $10.62M
[2/28/2024 4:10 PM]
127.92 -9.58 
(-6.96%)
138.00 0.50 
(0.36%)
55.25 - 159.89 1,624,472 1,020,000 3,225
01-11-2023 AH SRPT Sarepta Therapeutics, Inc. 10,040 -0.46 -1.63 -2.94 Sarepta Therapeutics GAAP EPS of -$0.46 beats by $0.80, revenue of $331.8M beats by $45.03M
[11/1/2023 4:13 PM]
77.76 1.24 
(1.62%)
77.76 0.0 
(0.00%)
55.25 - 159.89 3,638,270 3,770,000 12,899
02-08-2023 AH SRPT Sarepta Therapeutics, Inc. 10,100 -0.27 -1.89 -2.65 Sarepta Therapeutics Non-GAAP EPS of -$0.85 beats by $0.15, revenue of $261.2M beats by $5.36M
[8/2/2023 4:09 PM]
107.30 2.11 
(2.00%)
105.19 0.0 
(0.00%)
92.54 - 159.89 1,272,247 980,000 8,410
02-05-2023 AH 4:05 PM ET
(May 2)
SRPT Sarepta Therapeutics, Inc. 11,380 -1.44 -1.46 -1.20 Sarepta Therapeutics GAAP EPS of -$5.86 misses by $4.57, revenue of $253.5M beats by $12.03M
[5/2/2023 4:10 PM]
125.55 1.86 
(1.50%)
121.00 -2.69 
(-2.17%)
61.28 - 159.84 1,153,323 970,000 1,947
28-02-2023 AH 4:05 PM ET
(Feb 28)
SRPT Sarepta Therapeutics, Inc. 11,100 -1.24 -1.28 -1.42 Sarepta Therapeutics Q4 results mixed
[2/28/2023 4:10 PM]
145.24 23.11 
(18.92%)
143.03 20.90 
(17.11%)
61.28 - 152.30 6,289,018 1,050,000 179,452
02-11-2022 AH 4:05 PM ET
(Nov 2)
SRPT Sarepta Therapeutics, Inc. 9,980 -2.94 -1.21 -0.60 Sarepta Therapeutics Non-GAAP EPS of -$0.80 misses by $0.06, revenue of $230.27M misses by $4.28M
[11/2/2022 4:18 PM]
105.00 -8.43 
(-7.43%)
113.42 0.0 
(0.00%)
61.28 - 120.23 2,114,238 940,000 18,027
02-08-2022 AH 4:05 PM ET
(Aug 2)
SRPT Sarepta Therapeutics, Inc. 7,350 -2.65 -1.07 -1.02 Sarepta Therapeutics Non-GAAP EPS of -$1.18 misses by $0.58, revenue of $233.49M beats by $12.68M
[8/2/2022 4:23 PM]
96.13 2.12 
(2.26%)
94.35 0.34 
(0.36%)
61.28 - 101.24 2,227,964 910,000 969
04-05-2022 AH 4:05 PM ET
(May 4)
SRPT Sarepta Therapeutics 6,328 -1.20 -1.35 0.00 Sarepta Therapeutics Non-GAAP EPS of -$0.56 beats by $0.47, revenue of $210.8M beats by $2.55M
[5/4/2022 4:08 PM]
71.18 -1.57 
(-2.16%)
75.00 2.25 
(3.09%)
61.31 - 101.24 623,074 720,000 1,095
01-03-2022 AH 4:00 PM ET
(Mar 1)
SRPT Sarepta Therapeutics, Inc. 6,620 -1.42 -1.21 -2.40 Sarepta Therapeutics Non-GAAP EPS of -$0.77 beats by $0.37, revenue of $201.46M beats by $2.98M
[3/1/2022 4:09 PM]
79.63 3.61 
(4.75%)
75.00 -1.02 
(-1.34%)
61.31 - 101.24 1,085,450 640,000 428
03-11-2021 AH 4:05 PM ET
(Nov 3)
SRPT Sarepta Therapeutics, Inc. 6,890 -0.60 -1.86 -2.50 Sarepta Therapeutics EPS beats by $1.37, beats on revenue, raises product guidance
[11/3/2021 4:09 PM]
87.07 0.54 
(0.62%)
86.97 -0.10 
(-0.11%)
65.30 - 181.83 1,445,797 930,000 24,232
04-08-2021 AH 4:05 PM ET
(Aug 4)
SRPT Sarepta Therapeutics, Inc. 5,470 -1.02 -1.03 -1.93 Sarepta Therapeutics EPS misses by $0.23, beats on revenue
[8/4/2021 4:16 PM]
78.53 11.03 
(16.34%)
71.77 4.27 
(6.33%)
65.30 - 181.83 2,297,537 640,000 39,045
05-05-2021 AH 4:05 PM ET
(May 5)
SRPT Sarepta Therapeutics, Inc. 5,650 -2.10 -2.01 -0.23 Sarepta Therapeutics EPS beats by $0.03, beats on revenue
[5/5/2021 4:13 PM]
74.61 1.84 
(2.53%)
74.61 0.0 
(0.00%)
68.04 - 181.83 2,082,817 1,070,000 12,769
01-03-2021 AH 4:05 PM ET
(Mar 1)
SRPT Sarepta Therapeutics, Inc. 6,730 -2.40 -1.99 -3.16 Sarepta Therapeutics EPS misses by $0.38, misses on revenue
[3/1/2021 4:09 PM]
88.83 1.80 
(2.07%)
85.00 -2.03 
(-2.33%)
77.01 - 181.83 1,566,140 1,488,746 13,431
05-11-2020 AH 4:05 PM ET
(Nov 5)
SRPT Sarepta Therapeutics, Inc. 11,100 -2.50 -1.89 -1.70 Sarepta Therapeutics EPS misses by $0.02, beats on revenue
[11/5/2020 4:26 PM]
125.66 -19.49 
(-13.43%)
141.00 -4.15 
(-2.86%)
78.06 - 175.00 4,365,515 585,144 72,417
05-08-2020 AH 4:05 PM ET
(Aug 5)
SRPT Sarepta Therapeutics, Inc. 11,970 -1.93 -1.73 -3.74 Sarepta Therapeutics EPS misses by $0.20, beats on revenue
[8/5/2020 4:10 PM]
154.52 -4.36 
(-2.75%)
157.00 -1.89 
(-1.19%)
72.05 - 175.00 377,442 602,323 341
06-05-2020 AH SRPT Sarepta Therapeutics, Inc. 9,230 -0.23 -2.17 -1.07 0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0